Advocates call for FDA to take tougher stance on postmarket safety studies.
Bridget M
BM
Kuehn
D018427:Breast Implants / Q000009:adverse effects* / Q000592:standards; D002986:Clinical Trials as Topic; D003625:Data Collection; D018795:Device Approval / Q000592:standards*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010352:Patient Dropouts; D011358:Product Surveillance, Postmarketing / Q000592:standards; D012828:Silicones / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D012828:Silicones